These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 26862581)

  • 1. Data in support of NFκB and JNK pathways involvement in TLR3-mediated HIV-1 transactivation, expression of IL-6 and transcription factors associated with HIV-1 replication.
    Bhargavan B; Woollard SM; Kanmogne GD
    Data Brief; 2016 Mar; 6():345-51. PubMed ID: 26862581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptor-3 mediates HIV-1 transactivation via NFκB and JNK pathways and histone acetylation, but prolonged activation suppresses Tat and HIV-1 replication.
    Bhargavan B; Woollard SM; Kanmogne GD
    Cell Signal; 2016 Feb; 28(2):7-22. PubMed ID: 26569339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-Like Receptor-3 Mediates HIV-1-Induced Interleukin-6 Expression in the Human Brain Endothelium via TAK1 and JNK Pathways: Implications for Viral Neuropathogenesis.
    Bhargavan B; Kanmogne GD
    Mol Neurobiol; 2018 Jul; 55(7):5976-5992. PubMed ID: 29128906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 Tat protein induces IL-10 production in monocytes by classical and alternative NF-kappaB pathways.
    Leghmari K; Bennasser Y; Bahraoui E
    Eur J Cell Biol; 2008 Dec; 87(12):947-62. PubMed ID: 18760861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor 3 signaling inhibits simian immunodeficiency virus replication in macrophages from rhesus macaques.
    Sang M; Liu JB; Dai M; Wu JG; Ho WZ
    Antiviral Res; 2014 Dec; 112():103-12. PubMed ID: 25453343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HDAC1/NFκB pathway is involved in curcumin inhibiting of Tat-mediated long terminal repeat transactivation.
    Zhang HS; Ruan Z; Sang WW
    J Cell Physiol; 2011 Dec; 226(12):3385-91. PubMed ID: 21344388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
    Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
    Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple signaling pathways contribute to synergistic TLR ligand-dependent cytokine gene expression in human monocyte-derived macrophages and dendritic cells.
    Mäkelä SM; Strengell M; Pietilä TE; Osterlund P; Julkunen I
    J Leukoc Biol; 2009 Apr; 85(4):664-72. PubMed ID: 19164128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms involved in HIV-1 Tat-mediated induction of IL-6 and IL-8 in astrocytes.
    Nookala AR; Kumar A
    J Neuroinflammation; 2014 Dec; 11():214. PubMed ID: 25539898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptor 3 mediates a more potent antiviral response than Toll-like receptor 4.
    Doyle SE; O'Connell R; Vaidya SA; Chow EK; Yee K; Cheng G
    J Immunol; 2003 Apr; 170(7):3565-71. PubMed ID: 12646618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulating HIV-1 replication by RNA interference directed against human transcription elongation factor SPT5.
    Ping YH; Chu CY; Cao H; Jacque JM; Stevenson M; Rana TM
    Retrovirology; 2004 Dec; 1():46. PubMed ID: 15620346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-beta.
    Jiang Z; Mak TW; Sen G; Li X
    Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3533-8. PubMed ID: 14982987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 infection induces acetylation of NPM1 that facilitates Tat localization and enhances viral transactivation.
    Gadad SS; Rajan RE; Senapati P; Chatterjee S; Shandilya J; Dash PK; Ranga U; Kundu TK
    J Mol Biol; 2011 Jul; 410(5):997-1007. PubMed ID: 21763502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of Toll-interleukin 1 receptor mediated signaling.
    Li X; Qin J
    J Mol Med (Berl); 2005 Apr; 83(4):258-66. PubMed ID: 15662540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential Mechanisms of Inflammation and Endothelial Dysfunction by HIV-1 Subtype-B and Recombinant CRF02_AG Tat Proteins on Human Brain Microvascular Endothelial Cells: Implications for Viral Neuropathogenesis.
    Bhargavan B; Kanmogne GD
    Mol Neurobiol; 2018 Feb; 55(2):1352-1363. PubMed ID: 28127697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of toll-like receptors by human muscle cells in vitro and in vivo: TLR3 is highly expressed in inflammatory and HIV myopathies, mediates IL-8 release and up-regulation of NKG2D-ligands.
    Schreiner B; Voss J; Wischhusen J; Dombrowski Y; Steinle A; Lochmüller H; Dalakas M; Melms A; Wiendl H
    FASEB J; 2006 Jan; 20(1):118-20. PubMed ID: 16293707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune complexes containing scleroderma-specific autoantibodies induce a profibrotic and proinflammatory phenotype in skin fibroblasts.
    Raschi E; Chighizola CB; Cesana L; Privitera D; Ingegnoli F; Mastaglio C; Meroni PL; Borghi MO
    Arthritis Res Ther; 2018 Aug; 20(1):187. PubMed ID: 30157947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of IL-27 p28 by Theiler's virus-infected macrophages depends on TLR3 and TLR7 activation of JNK-MAP-kinases.
    Hause L; Al-Salleeh FM; Petro TM
    Antiviral Res; 2007 Nov; 76(2):159-67. PubMed ID: 17675254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Tat-mediated transactivation and HIV replication with Tat mutant and repressor domain fusion proteins.
    Fraisier C; Abraham DA; van Oijen M; Cunliffe V; Irvine A; Craig R; Dzierzak EA
    Gene Ther; 1998 Jul; 5(7):946-54. PubMed ID: 9813666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatory actions of Syk inhibitors in macrophages involve non-specific inhibition of toll-like receptors-mediated JNK signaling pathway.
    Lin YC; Huang DY; Chu CL; Lin WW
    Mol Immunol; 2010 Apr; 47(7-8):1569-78. PubMed ID: 20138367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.